Education
About Us
Working with TipRanks
Follow Us
Perseus Proteomics, Inc. (JP:4882)
:4882
4882 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥298.00 - ¥1,113.00
Previous CloseN/A
Volume686.20K
Average Volume (3M)1.98M
Market Cap
¥6.05B
Enterprise Value¥6.41B
Total Cash (Recent Filing)¥1.88B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.91
Next Earnings
May 09, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-65.31
Shares Outstanding14,749,500
10 Day Avg. Volume1,121,210
30 Day Avg. Volume1,979,196
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Perseus Proteomics, Inc. News
PremiumCompany Announcements
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
PremiumCompany Announcements
Perseus Proteomics Updates PPMX-T003 Project Details
PremiumCompany Announcements
Perseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
PremiumCompany Announcements
Perseus Proteomics Reports Financial Adjustments and LossesPremiumCompany Announcements
Perseus Proteomics Reports Increased Sales but Continued Losses
PremiumCompany Announcements
Perseus Proteomics Extends Clinical Trial for Rare Leukemia
PremiumCompany Announcements
Perseus Proteomics Reports Promising Trial Results---
4882 FAQ
What was Perseus Proteomics, Inc.’s price range in the past 12 months?
Perseus Proteomics, Inc. lowest stock price was ¥298.00 and its highest was ¥1113.00 in the past 12 months.
What is Perseus Proteomics, Inc.’s market cap?
Perseus Proteomics, Inc.’s market cap is ¥6.05B.
When is Perseus Proteomics, Inc.’s upcoming earnings report date?
Perseus Proteomics, Inc.’s upcoming earnings report date is May 09, 2025 which is in 8 days.
How were Perseus Proteomics, Inc.’s earnings last quarter?
Perseus Proteomics, Inc. released its earnings results on Feb 14, 2025. The company reported -¥13.3 earnings per share for the quarter, missing the consensus estimate of N/A by -¥13.3.
Is Perseus Proteomics, Inc. overvalued?
According to Wall Street analysts Perseus Proteomics, Inc.’s price is currently Overvalued.
Does Perseus Proteomics, Inc. pay dividends?
Perseus Proteomics, Inc. does not currently pay dividends.
What is Perseus Proteomics, Inc.’s EPS estimate?
Perseus Proteomics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Perseus Proteomics, Inc. have?
Perseus Proteomics, Inc. has 14,749,500 shares outstanding.
What happened to Perseus Proteomics, Inc.’s price movement after its last earnings report?
Perseus Proteomics, Inc. reported an EPS of -¥13.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.688%.
Which hedge fund is a major shareholder of Perseus Proteomics, Inc.?
Currently, no hedge funds are holding shares in JP:4882
---
Company Description
Perseus Proteomics, Inc.
Perseus Proteomics Inc., a drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery activities; and antibody research support activities comprising hybridoma antibody sequencing, antibody protein production, and contract antibody research activities, as well as supply of antibody products. Its product pipeline includes PPMX-T001, an anti-hepatocarcinoma antibody; PPMX-T002, an anticancer drug; PPMX-T003, a drug for the treatment of adult T-cell; and PPMX-T004, an antibody drug conjugate. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
---
Technical Analysis
AnGes
―
Sumitomo Dainippon Pharma Co
―
Daiichi Sankyo Company
―
Kyowa Kirin Co
―
Shionogi & Co
―
---